English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Rare pediatric disease voucher program reauthorized as part of narrowly approved spending bill
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Puerto Rico aims for revival as Amgen and Lilly invest billions in local facilities
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Study finds pink noise may reduce REM sleep quality
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Pharma faces mounting pressure over opaque drug pricing as calls grow for transparency
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

FARE launches new PSA featuring Tia Mowry in Ready to Act campaign
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

FDA launches PreCheck pilot program to aid U.S. drug manufacturing
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes